Tokyo Center Clinic
Chuo-ku, Tokyo 103-0028
2 studies enrolling now · 6 studies all time
What they study most
Obesity, Overweight, Overweight and/or Obesity, SARS-CoV-2, SARS-CoV-2 Infection, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity — Recruiting now
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease — Starting soon
- Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed
- A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity — Completed
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin — Completed
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — Completed